Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials
-
- Avraham Karasik
- Chaim Sheba Medical Center Tel HashomerIsrael
-
- Pablo Aschner
- Colombian Diabetes Association BogotáColombia
-
- Harvey Katzeff
- Merck Research Laboratories Rahway, NJUSA
-
- Michael J. Davies
- Merck Research Laboratories Rahway, NJUSA
-
- Peter P. Stein
- Merck Research Laboratories Rahway, NJUSA
書誌事項
- 公開日
- 2008-01-07
- DOI
-
- 10.1185/030079908x261069
- 公開者
- Informa Healthcare
この論文をさがす
収録刊行物
-
- Current Medical Research and Opinion
-
Current Medical Research and Opinion 24 (2), 489-496, 2008-01-07
Informa Healthcare